Canada Post Corp Registered Pension Plan Acquires New Position in DaVita Inc. (NYSE:DVA)

Canada Post Corp Registered Pension Plan bought a new position in DaVita Inc. (NYSE:DVA) in the 4th quarter, HoldingsChannel.com reports. The fund bought 368 shares of the company’s stock, valued at approximately $55,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. SBI Securities Co. Ltd. bought a new stake in shares of DaVita in the 4th quarter valued at about $41,000. Venturi Wealth Management LLC lifted its position in DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock valued at $61,000 after purchasing an additional 152 shares during the last quarter. Versant Capital Management Inc grew its holdings in shares of DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after purchasing an additional 169 shares during the last quarter. Blue Trust Inc. increased its stake in shares of DaVita by 39.7% in the fourth quarter. Blue Trust Inc. now owns 461 shares of the company’s stock worth $76,000 after buying an additional 131 shares during the period. Finally, Jones Financial Companies Lllp raised its holdings in DaVita by 28.6% during the 4th quarter. Jones Financial Companies Lllp now owns 517 shares of the company’s stock valued at $77,000 after buying an additional 115 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on DVA shares. StockNews.com upgraded shares of DaVita from a “hold” rating to a “buy” rating in a research report on Thursday, April 10th. Cowen restated a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price objective on DaVita in a report on Friday, February 21st. Finally, Barclays upped their target price on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a report on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, DaVita currently has a consensus rating of “Hold” and an average target price of $166.33.

DaVita Stock Down 0.9 %

Shares of NYSE:DVA opened at $140.21 on Friday. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. DaVita Inc. has a 52-week low of $125.64 and a 52-week high of $179.60. The firm has a market capitalization of $11.22 billion, a P/E ratio of 13.05, a P/E/G ratio of 1.07 and a beta of 1.04. The stock has a 50 day moving average price of $149.80 and a 200-day moving average price of $156.17.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, equities research analysts anticipate that DaVita Inc. will post 10.76 EPS for the current fiscal year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.